Tumor regression and growth rates determined in five intramural NCI prostate cancer trials: the growth rate constant as an indicator of therapeutic efficacy.

Source:http://linkedlifedata.com/resource/pubmed/id/21106727

Clin. Cancer Res. 2011 Feb 15 17 4 907-17

Download in:

View as

General Info

PMID
21106727